StockData
NeuroSense Therapeutics Ltd. logo

NeuroSense Therapeutics Ltd. (NRSN) stock

NRSNNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NRSNW
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$1.37−0.14 (-9.27%)

Close on Nov 18, 2026Market cap $2.52MP/E –Yield –

NeuroSense Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

NeuroSense Therapeutics's price to book ratio was 16.2× on Jul 31, 2025, against 2.6× a year earlier. Over the last 2 years it ranged from 0.0× to 17.0×, with a median of 2.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jul 31, 202516.2×+16.1
2024Jan 31, 20240.1×+0.0
2023Dec 29, 20230.1×−0.3
2022Jul 29, 20220.3×–

More NeuroSense Therapeutics figures

See a number that looks wrong?